The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-time detection of patient-reported outcomes (PRO) through an app: A Brazilian experience.
 
Alessandra Menezes Morelle
No Relationships to Disclose
 
Geraldine Eltz de Lima
No Relationships to Disclose
 
Nathalia D'Agustini
No Relationships to Disclose
 
Fernando Castilho Venero
No Relationships to Disclose
 
Carlos H. Barrios
Stock and Other Ownership Interests - Biomarker; MedSIR; Tummi
Honoraria - Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Libbs; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Research Funding - AB Science; Abbvie; Abraxis BioScience; Amgen; Asana Biosciences; Astellas Pharma; AstraZeneca; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celgene; Clinica Atlantis; Covance; Daiichi Sankyo; Daiichi Sankyo; Exelixis; GlaxoSmithKline; GlaxoSmithKline; Halozyme; ImClone Systems; INC Research; inVentiv Health; Janssen; LEO Pharma; Lilly; Medivation; Merck; Merrimack; Millennium; Mylan; Novartis; Pfizer; Roche/Genentech; Sanofi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; MSD Oncology; Novartis; Pfizer; Roche/Genentech